Related Experiment Video
Updated: Jul 13, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis
L M Nilsson1, U B Keller, C Yang
1Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
p18(Ink4c) functions as a dedicated inhibitor of cyclin-D-dependent kinases. Loss of Ink4c predisposes mice to tumor development and, in a dose-dependent manner, complements the tumor-promoting effects of various oncogenes. We have now addressed whether Ink4c loss impacts B-cell tumor development in the Emu-Myc transgenic mouse, a model of human Burkitt lymphoma. Loss of one or both alleles did not influence the onset of lymphoma in Emu-Myc transgenics, and did not appreciably affect Myc's proliferative or apoptotic responses in precancerous B cells. Nevertheless, Ink4c loss modulated the effects of Myc-induced transformation by decreasing the frequency of Arf loss, an ordinarily common event in Emu-Myc-induced lymphomas.
Insights
The tumor suppressor p18 (Inhibitor of cyclin-dependent kinase 4c) loss did not affect lymphoma onset in Emu-Myc mice. However, it reduced the frequency of Arf loss, a common event in these B-cell lymphomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- p18(Ink4c) is a cyclin-dependent kinase inhibitor that suppresses tumor development.
- Loss of Ink4c predisposes mice to tumors and enhances oncogene effects.
- The Emu-Myc transgenic mouse model mimics human Burkitt lymphoma.
Purpose of the Study:
- To investigate the impact of Ink4c loss on B-cell tumor development in the Emu-Myc mouse model.
- To determine if Ink4c deficiency influences lymphoma onset or progression.
- To analyze the interplay between Ink4c, Myc, and Arf in B-cell lymphomagenesis.
Main Methods:
- Utilized Emu-Myc transgenic mice with varying Ink4c allelic status (wild-type, heterozygous, homozygous null).
- Monitored lymphoma onset and progression in these mouse cohorts.
- Assessed proliferative and apoptotic responses in precancerous B cells.
- Quantified the frequency of Arf loss in developed lymphomas.
Main Results:
- Loss of one or both Ink4c alleles did not alter the onset of lymphoma in Emu-Myc transgenics.
- Ink4c deficiency did not significantly affect Myc-driven proliferation or apoptosis in early B cells.
- Ink4c loss significantly decreased the frequency of Arf loss in Emu-Myc lymphomas.
Conclusions:
- Ink4c is not a critical determinant for lymphoma initiation in the Emu-Myc model.
- Ink4c modulates Myc-induced transformation by influencing alternative genetic events, specifically reducing Arf loss.
- This suggests a complex role for Ink4c in tumor suppression beyond direct cell cycle inhibition, potentially by impacting the selection of cooperating genetic alterations.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
07:36Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of CDK Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells
Somatic cells are...